Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B2,11 | Lung | Primary cancer | 405 | Stromal | 40.5% | 0.38 | 0.96 |
| NSCLC_38242124__IMC__86_B2,12 | Lung | Primary cancer | 2,772 | Tumor/Malignant | 63.2% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__86_B2,13 | Lung | Primary cancer | 3,107 | Tumor/Malignant | 31.2% | 0.89 | 0.38 |
| NSCLC_38242124__IMC__86_B2,14 | Lung | Primary cancer | 786 | Tumor/Malignant | 30.0% | 0.91 | 0.32 |
| NSCLC_38242124__IMC__86_B2,2 | Lung | Primary cancer | 100 | Stromal | 58.0% | 0.69 | 0.65 |
| NSCLC_38242124__IMC__86_B2,3 | Lung | Primary cancer | 3,266 | Tumor/Malignant | 54.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__86_B2,4 | Lung | Primary cancer | 3,952 | Tumor/Malignant | 54.2% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__86_B2,5 | Lung | Primary cancer | 1,063 | Tumor/Malignant | 53.5% | 0.95 | 0.12 |
| NSCLC_38242124__IMC__86_B2,6 | Lung | Primary cancer | 3,368 | Tumor/Malignant | 88.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_B3,1 | Lung | Primary cancer | 3,965 | Tumor/Malignant | 63.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B3,10 | Lung | Primary cancer | 3,467 | Tumor/Malignant | 47.7% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__86_B3,11 | Lung | Primary cancer | 1,306 | Stromal | 53.4% | 0.91 | 0.24 |
| NSCLC_38242124__IMC__86_B3,12 | Lung | Primary cancer | 4,546 | Tumor/Malignant | 44.5% | 1.00 | 0.05 |
| NSCLC_38242124__IMC__86_B3,13 | Lung | Primary cancer | 2,355 | Tumor/Malignant | 61.2% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__86_B3,14 | Lung | Primary cancer | 959 | Tumor/Malignant | 79.5% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__86_B3,2 | Lung | Primary cancer | 2,582 | Tumor/Malignant | 33.7% | 0.84 | 0.43 |
| NSCLC_38242124__IMC__86_B3,3 | Lung | Primary cancer | 4,147 | Tumor/Malignant | 50.4% | 0.94 | 0.29 |
| NSCLC_38242124__IMC__86_B3,4 | Lung | Primary cancer | 4,451 | Immune | 41.6% | 0.89 | 0.29 |
| NSCLC_38242124__IMC__86_B3,6 | Lung | Primary cancer | 2,042 | Tumor/Malignant | 31.0% | 0.89 | 0.36 |
| NSCLC_38242124__IMC__86_B4,10 | Lung | Primary cancer | 1,347 | Tumor/Malignant | 86.9% | 0.98 | 0.05 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B2,11 | Lung | Primary cancer | 405 | Stromal | 43.7% | 0.38 | 0.98 |
| NSCLC_38242124__IMC__86_B2,12 | Lung | Primary cancer | 2,772 | Tumor/Malignant | 53.3% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_B2,13 | Lung | Primary cancer | 3,107 | Tumor/Malignant | 25.7% | 0.92 | 0.30 |
| NSCLC_38242124__IMC__86_B2,14 | Lung | Primary cancer | 786 | Tumor/Malignant | 30.2% | 0.91 | 0.32 |
| NSCLC_38242124__IMC__86_B2,2 | Lung | Primary cancer | 100 | Stromal | 62.0% | 0.71 | 0.69 |
| NSCLC_38242124__IMC__86_B2,3 | Lung | Primary cancer | 3,266 | Tumor/Malignant | 54.3% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__86_B2,4 | Lung | Primary cancer | 3,952 | Tumor/Malignant | 55.0% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__86_B2,5 | Lung | Primary cancer | 1,063 | Tumor/Malignant | 40.4% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__86_B2,6 | Lung | Primary cancer | 3,368 | Tumor/Malignant | 89.6% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B3,1 | Lung | Primary cancer | 3,965 | Tumor/Malignant | 64.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_B3,10 | Lung | Primary cancer | 3,467 | Tumor/Malignant | 44.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__86_B3,11 | Lung | Primary cancer | 1,306 | Stromal | 34.2% | 0.73 | 0.59 |
| NSCLC_38242124__IMC__86_B3,12 | Lung | Primary cancer | 4,546 | Tumor/Malignant | 59.1% | 0.97 | 0.15 |
| NSCLC_38242124__IMC__86_B3,13 | Lung | Primary cancer | 2,355 | Tumor/Malignant | 62.1% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B3,14 | Lung | Primary cancer | 959 | Tumor/Malignant | 71.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B3,2 | Lung | Primary cancer | 2,582 | Tumor/Malignant | 30.0% | 0.86 | 0.38 |
| NSCLC_38242124__IMC__86_B3,3 | Lung | Primary cancer | 4,147 | Tumor/Malignant | 48.9% | 0.94 | 0.28 |
| NSCLC_38242124__IMC__86_B3,4 | Lung | Primary cancer | 4,451 | Lymphoid | 32.3% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__86_B3,6 | Lung | Primary cancer | 2,042 | Tumor/Malignant | 23.3% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__86_B4,10 | Lung | Primary cancer | 1,347 | Tumor/Malignant | 62.4% | 0.99 | 0.05 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B2,11 | Lung | Primary cancer | 405 | Fibroblast | 43.2% | 0.38 | 1.03 |
| NSCLC_38242124__IMC__86_B2,12 | Lung | Primary cancer | 2,772 | Tumor/Malignant cell | 60.7% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__86_B2,13 | Lung | Primary cancer | 3,107 | Tumor/Malignant cell | 32.1% | 0.88 | 0.40 |
| NSCLC_38242124__IMC__86_B2,14 | Lung | Primary cancer | 786 | Tumor/Malignant cell | 37.0% | 0.86 | 0.40 |
| NSCLC_38242124__IMC__86_B2,2 | Lung | Primary cancer | 100 | Fibroblast | 68.0% | 0.56 | 0.93 |
| NSCLC_38242124__IMC__86_B2,3 | Lung | Primary cancer | 3,266 | Tumor/Malignant cell | 69.2% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__86_B2,4 | Lung | Primary cancer | 3,952 | Tumor/Malignant cell | 54.9% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__86_B2,5 | Lung | Primary cancer | 1,063 | Tumor/Malignant cell | 53.0% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__86_B2,6 | Lung | Primary cancer | 3,368 | Tumor/Malignant cell | 89.5% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B3,1 | Lung | Primary cancer | 3,965 | Tumor/Malignant cell | 80.0% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__86_B3,10 | Lung | Primary cancer | 3,467 | Tumor/Malignant cell | 47.7% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__86_B3,11 | Lung | Primary cancer | 1,306 | Fibroblast | 53.0% | 0.88 | 0.28 |
| NSCLC_38242124__IMC__86_B3,12 | Lung | Primary cancer | 4,546 | Tumor/Malignant cell | 65.2% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__86_B3,13 | Lung | Primary cancer | 2,355 | Tumor/Malignant cell | 76.5% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__86_B3,14 | Lung | Primary cancer | 959 | Tumor/Malignant cell | 71.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B3,2 | Lung | Primary cancer | 2,582 | Tumor/Malignant cell | 35.5% | 0.82 | 0.48 |
| NSCLC_38242124__IMC__86_B3,3 | Lung | Primary cancer | 4,147 | Tumor/Malignant cell | 49.2% | 0.94 | 0.28 |
| NSCLC_38242124__IMC__86_B3,4 | Lung | Primary cancer | 4,451 | T cell | 29.9% | 0.34 | 1.05 |
| NSCLC_38242124__IMC__86_B3,6 | Lung | Primary cancer | 2,042 | Tumor/Malignant cell | 30.4% | 0.90 | 0.35 |
| NSCLC_38242124__IMC__86_B4,10 | Lung | Primary cancer | 1,347 | Tumor/Malignant cell | 87.2% | 0.98 | 0.05 |